Rare
lephants
Screener
Toggle theme
MiMedx Group, Inc.
MDXG
·
Healthcare, Medical Devices, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2018
FY2017
FY2016
FY2015
FY2014
Total Cash from Operations:
$17.7M
Line Item
Value
% of Total
Other Investing
$12.2M
68.8%
Other Financing
$2.1M
12.1%
Working Capital
$871.0K
4.9%
Net Cash Flow
$2.5M
14.2%
Download CSV
